Stay updated on Safety & Activity of SBT6050 with HER2 Therapies Clinical Trial
Sign up to get notified when there's something new on the Safety & Activity of SBT6050 with HER2 Therapies Clinical Trial page.

Latest updates to the Safety & Activity of SBT6050 with HER2 Therapies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry, v3.6.4, was added and the previous v3.6.3 entry was removed, reflecting an updated version in the study's history.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry v3.6.3 was added to the record history and the previous entry v3.6.2 was removed, reflecting an update to the record versions. This indicates a new version of the study record has been recorded.SummaryDifference0.1%

- Check42 days agoChange DetectedVersion history shows a new entry for Revision: v3.6.2 and removes the previous Revision: v3.6.0 entry. This reflects an update to the study's record history, aligning the displayed history with the latest versioning of the record.SummaryDifference0.1%

- Check56 days agoChange DetectedThe record history now shows 'No longer looking for participants,' indicating recruitment for this study has ended. The page revision is updated to v3.6.0, and the previous v3.5.5 tag has been removed.SummaryDifference0.6%

- Check64 days agoChange DetectedRevision: v3.5.5 was added to the history and Revision: v3.5.4 was removed, updating the page's version history. This reflects a newer revision entry in the study record's maintenance log.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page's revision history now shows v3.5.4, replacing v3.5.3. This indicates a minor version update to the study record history page.SummaryDifference0.1%

Stay in the know with updates to Safety & Activity of SBT6050 with HER2 Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Activity of SBT6050 with HER2 Therapies Clinical Trial page.